Patents
US Patent 10,792,232. Methods to deliver antifibrinolytic drugs for anti-aging results. Filed Oct. 17, 2017.
US Patent 11,241,405. Methods and Compositions to Enhance a Non-Surgical Medical Treatment. Filed April 4, 2017.
Australian Patent 2018248422. Methods to Enhance a Non-Surgical Medical Treatment. Filed April 4, 2018.
Brazilian Patent BR1120190207660. Methods to Enhance a Non-Surgical Medical Treatment. Filed April 4, 2018.
Chinese Patent ZL201880037169.0. Methods to Enhance a Non-Surgical Medical Treatment. Filed April 4, 2018.
Hong Kong Patent HK40014749. Methods to Enhance a Non-Surgical Medical Treatment. Filed April 4, 2018.
Indian Patent 396628. Methods to Enhance a Non-Surgical Medical Treatment. Filed April 4, 2018.
New Zealand Patent 2019/07265. Methods to Enhance a Non-Surgical Medical Treatment. Filed April 4, 2018.
U.S. Patent 11,413,279. Methods and Compositions for the Antiviral Use of Synthetic Lysine Analogs and Mimetics (Topical use vs HIV lesions)
Indian Patent 523320. Methods and Compositions for the Antiviral Use of Synthetic Lysine Analogs and Mimetics. Filed August 9, 2018.
Mexican Patent 409761. Methods and Compositions for the Antiviral Use of Synthetic Lysine Analogs and Mimetics. Filed August 9, 2018.
New Zealand Patent 2020/01472. Methods and Compositions for the Antiviral Use of Synthetic Lysine Analogs and Mimetics. Filed August 9, 2018.
U.S. Patent 11,576,882. Method to Deliver Anti-Fibrinolytic Drugs to Mitigate Damage to the Brain Caused by Concussive Impact. Filed November 1, 2016.
New Zealand Patent 2022/05867. Synergistic Combinations of Synthetic Lysine Analogs, Derivatives, or Mimetics and Pharmaceutical Agents for Enhanced Efficacy of the Pharmaceutical Agents. Filed October 29, 2020.
PCT/US2018/026086. Methods to enhance a non-surgical medical treatment (anti-bruising). Filed April 4, 2018.
PCT/US18/46023. Methods and Compositions for the Antiviral Use of Synthetic Lysine Analogs and Mimetics. Filed August 9, 2018.
PCT/US20/57877. Synergistic Combinations of Synthetic Lysine Analogs, Derivatives, or Mimetics and Pharmaceutical Agents for Enhanced Efficacy of the Pharmaceutical Agents. Filed October 29, 2020.
PCT/US2021/015953. Methods and Compositions for AntiMicrobial Use of Synthetic Lysine Analogs, Derivatives, and Mimetics, and Prodrugs. Filed January 30, 2021.
PCT/US2021/016238. Methods and Compositions for Treatment of Diseases. Filed February 2, 2021.
PCT/2023/016391. Tranexamic Class Arginine and Histidine Mimics as Therapeutic Agents. Filed March 27, 2023.
Multiple patents pending covering methods and compositions for use of lysine analogs and related agents against cancer, microbes, and aging conditions, among other things.
Trademarks
We claim trademark rights in the terms “Tranexamic Lysine”, “Tranexamic Arginine”, “Tranexamic Histidine”, and the “Tranexamic Class Antagonists”.
We also claim trademark rights in the acronyms “TXK”, “TXR”, “TXH”, and “TXCA”.